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Losing sense of smell or taste 
and developing COVID-19 were 
strongly associated. Participants 
who lost their sense of smell or taste 
were more likely to have a positive 
SARS-CoV-2 test than those who 
did not report these symptoms 
(odds ratio 4·9, 95% CI 1·4–17·1, 
p=0·01). 97 participants responded to a 
follow-up survey done between May 22 
and 27, 2020; 45 (46%) reported that 
they had completely regained 
their sense of smell or taste, 
41 (42%) had recovered partially, and 
seven (7%) had not recovered (not 
applicable for four [4%] responders). 
71 (73%) of 97 responders had 
continued to work as normal. Around 
two-thirds of participants reported 
loss of sense of smell or taste in the 
previous 2 months, which is highly 
indicative of SARS-CoV-2 infection 
(appendix p 2). In comparison, the 
prevalence of self-reported smell loss 
varies between 1·4% and 15·3% across 
published studies.4,5 
To date, testing for health-care 
workers in the National Health Service 
has been scarce and only recently has 
been made more widely available. 
Thus, a large proportion of health-
care workers might have already been 
infected with SARS-CoV-2 and had 
only mild symptoms, resulting in only 
a small number of health-care workers 
being tested. In conclusion, awareness 
and early recognition of anosmia 
and hyposmia is needed to identify, 
urgently test, and isolate affected 
health-care workers to prevent further 
spread of disease.
Anosmia and hyposmia 
in health-care workers 
with undiagnosed 
SARS-CoV-2 infection
On May 18 2020, Public Health 
England added new loss of taste or 
smell to the recognised symptoms 
associated with COVID-19, consistent 
with those listed by the Centers 
of Disease Control and Prevention 
(Atlanta, GA, USA) and WHO.1,2 The 
identification of loss of sense of 
smell as a symptom of severe acute 
respiratory syndrome corona virus 2 
(SARS-CoV-2) is particularly important 
for frontline health-care workers who 
are at high risk of both contracting and 
spreading SARS-CoV-2.3 
A n o n y m o u s  s e l f - r e p o r t e d 
question naires were distributed 
to staff at Barts Health NHS Trust 
(London, UK). In total, 262 health-
care workers from four hospitals 
completed the questionnaire between 
April 17 and 23, 2020, of whom, 
59% were women, 58% were younger 
than 40 years, and 6% were older than 
60 years, provi ding a representative 
sample of the patient-facing workforce. 
73 (28%) of 262 participants had 
been tested for SARS-CoV-2; 56 of 
whom had a confirmed positive test 
by PCR. 168 (64%) of 262 responders 
reported losing their sense of smell or 
taste in the previous 2 months, with 
94 (48%) reporting mild symptoms, 
93 (48%) reporting moderate 
symptoms, and seven (4%) reporting 
severe symptoms. 
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